Publications
Publications
- March 2018 (Revised May 2018)
- HBS Case Collection
Celgene (B)
By: Malcolm Baker and Emily McComb
Abstract
Supplements the (A) case.
Keywords
Life Sciences; Biotechnology; Public Market Investing; Celgene; Revlimid; Hedge Fund; Growth Stocks; Valuation; Investment; Decision Choices and Conditions; Analysis; Biotechnology Industry
Citation
Baker, Malcolm, and Emily McComb. "Celgene (B)." Harvard Business School Supplement 218-099, March 2018. (Revised May 2018.)